First, hydroxyzine is a functional inhibitor of acid sphingomyelinase [17,18], and prior research supports that these molecules could be beneficial in COVID-19 patients, through potential subsequent antiviral and anti-inflammatory effects [7,8,17,19,20,21,22,23,24,25,26,27,28]. This evidence concerns the gene SMPD1 and COVID-19.